AI English summary of an SEC filing — figures as filed
The company said the employment of Eric P. Palmer will end on April 26, 2025, after it disclosed on March 13 that it had executed an Agreement and Release with Mr. Palmer on April 15.
Key points
AI summaryThe company said the employment of Eric P. Palmer will end on April 26, 2025, after it disclosed on March 13 that it had executed an Agreement and Release with Mr. Palmer on April 15.
The Cigna Group said it will pay Mr. Palmer $5.2 million in cash under the Agreement and Release, subject to the terms of the release. The payment reflects 78 weeks of base pay, 150% of his 2025 EIP target, and other items.
The company said stock options, restricted stock and SPSs scheduled to vest within 12 months of April 26 will continue to vest. It estimated the total value of this equity treatment at about $4.8 million, based on the closing price of $328.63 on April 15, 2025.
The company said stock options granted before 2021 will expire on the earlier of their original expiration date or 90 days after April 26, 2025. Options granted after 2020 will expire 90 days after April 26, 2026. The People Resources Committee will determine the percentage of SPS shares earned and the timing of payment.
Summary
AI-writtenAnalysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.
Eric P. Palmer Departure Date and Agreement and Release
The company said the employment of Eric P. Palmer will end on April 26, 2025, after it disclosed on March 13 that it had executed an Agreement and Release with Mr. Palmer on April 15.
Source · Based on the filing body and exhibits
Cash Payment Under Palmer Agreement of $5.2 million
The Cigna Group said it will pay Mr. Palmer $5.2 million in cash under the Agreement and Release, subject to the terms of the release. The payment reflects 78 weeks of base pay, 150% of his 2025 EIP target, and other items.
Source · Based on the filing body and exhibits
Equity Treatment and Estimated Value of About $4.8 million
The company said stock options, restricted stock and SPSs scheduled to vest within 12 months of April 26 will continue to vest. It estimated the total value of this equity treatment at about $4.8 million, based on the closing price of $328.63 on April 15, 2025.
Source · Based on the filing body and exhibits
Stock Option Expiration Terms and SPS Payout Decision
The company said stock options granted before 2021 will expire on the earlier of their original expiration date or 90 days after April 26, 2025. Options granted after 2020 will expire 90 days after April 26, 2026. The People Resources Committee will determine the percentage of SPS shares earned and the timing of payment.
Source · Based on the filing body and exhibits
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…